Drug Price — Lanton Law Blog

Posts tagged Drug Price

New Trans-Atlantic Drug Pricing Deal: What Supply Chain Stakeholders Must Know

In a major development for the global life-sciences landscape, the United States and the United Kingdom have reached an agreement in principle that reshapes how both countries approach pharmaceutical pricing and cross-border trade.

healthcare, life sciences, pharmaceuticals, PhRMA, prescription drug costs, trade, U.K., United KingdomRon LantonDecember 1, 2025Drug Price, drug pricing, pharmaceuticals, VPAG, U.K., U.S., life sciences, Section 232, 232 investigation

Lanton Law Moderates Most Favored Nation Panel for MJH Life Sciences

Lanton Law was honored to be selected as a moderator for the MJH Life Sciences panel titled ““Most Favored Nation Order: Legal Battles, Market Shifts, and the Future of Drug Pricing Reform.”

healthcare, life sciences, Medicare Part B, Most Favored Nation, pharmaceuticals, prescription drug costsRon LantonOctober 12, 2025MFN, Most-Favored-Nation (MFN) Pricing, Pfizer, Drug Price, Medicare Part B, Inflation Reduction Act, IRA, insurance, healthcare, pharmaceutical, PhRMA